Approach to the Patient With Type 2 Diabetes Requiring Add-On Medication
An erratum to this article was published (J Clin Endocrinol Metab, 17 Jun 2024 ↗)
Study context
- Population
- Patients with T2D requiring add-on medication
Methodological detailsApproach to the Patient
- Approach to the Patient
Main finding
As reported in the abstract
- Proposed practical tool providing stepwise guidance on add-on medication in T2D, using available data on medication efficacy (hemoglobin A1c (HbA1c)-lowering potency, distance from individualized HbA1c goal), with flexibility for clinician and patient preference
- Diminishing return of glucose-lowering efficacy as add-on agents are introduced; extent of cardiac and renal protection not fully understood
- Newer non-insulin agents may distract from insulin, the most potent agent available
Original publication
Approach to the Patient With Type 2 Diabetes Requiring Add-On Medication. J Clin Endocrinol Metab. Published 19 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →